Home The Word Brain Fast Track My Amedeo FAQ About Flying Publisher   

Fast Track

Ear2MemoryFree App | Free PDF | Web
Learning languages on your smartphone
By BSK

Free Abstracts

  Stroke

  Free Subscription


Articles published in Am J Med

Retrieve available abstracts of 30 articles:
HTML format
Text format



Single Articles


    April 2017
  1. RENDA G, Ricci F, De Caterina R
    Non-Vitamin K Antagonist Oral Anticoagulants for Cardioversion in Atrial Fibrillation: An Updated Meta-analysis.
    Am J Med. 2017;130:457-461.
    PubMed     Text format     Abstract available


    March 2017
  2. DALEN JE, Alpert JS
    Silent Atrial Fibrillation and Cryptogenic Strokes.
    Am J Med. 2017;130:264-267.
    PubMed     Text format     Abstract available


    February 2017
  3. MAZUREK M, Huisman MV, Lip GY
    Registries in Atrial Fibrillation: From Trials to Real-Life Clinical Practice.
    Am J Med. 2017;130:135-145.
    PubMed     Text format     Abstract available


    December 2016
  4. FAUCHIER L, Villejoubert O, Clementy N, Bernard A, et al
    Causes of Death and Influencing Factors in Patients with Atrial Fibrillation.
    Am J Med. 2016;129:1278-1287.
    PubMed     Text format     Abstract available


    November 2016
  5. DE SOUZA BRITO F, Mehta RH, Lopes RD, Harskamp RE, et al
    Non-Steroidal Anti-Inflammatory Drugs and Clinical Outcomes in Patients Undergoing Coronary Artery Bypass Surgery.
    Am J Med. 2016 Nov 22. pii: S0002-9343(16)31197.
    PubMed     Text format     Abstract available


  6. DALEN JE, Alpert JS
    Cryptogenic Strokes and Patent Foramen Ovales: What's the Right Treatment?
    Am J Med. 2016;129:1159-1162.
    PubMed     Text format     Abstract available


  7. BARRA ME, Fanikos J, Connors JM, Sylvester KW, et al
    Evaluation of Dose-Reduced Direct Oral Anticoagulant Therapy.
    Am J Med. 2016;129:1198-1204.
    PubMed     Text format     Abstract available


  8. EIKELBOOM J, Merli G
    Bleeding with Direct Oral Anticoagulants vs Warfarin: Clinical Experience.
    Am J Med. 2016;129.
    PubMed     Text format     Abstract available


  9. MILLING TJ JR, Kaatz S
    Preclinical and Clinical Data for Factor Xa and "Universal" Reversal Agents.
    Am J Med. 2016;129.
    PubMed     Text format     Abstract available


  10. VILLINES TC, Peacock WF
    Safety of Direct Oral Anticoagulants: Insights from Postmarketing Studies.
    Am J Med. 2016;129.
    PubMed     Text format     Abstract available


  11. MILLING TJ JR, Spyropoulos AC
    Re-Initiation of Dabigatran and Direct Factor Xa Antagonists After a Major Bleed.
    Am J Med. 2016;129.
    PubMed     Text format     Abstract available


    October 2016
  12. ALEXANDER GC, Iyer G, Lucas E, Lin D, et al
    Cardiovascular risks of exogenous testosterone use among men: A systematic review and meta-analysis.
    Am J Med. 2016 Oct 14. pii: S0002-9343(16)31024.
    PubMed     Text format     Abstract available


  13. RENDA G, Zimarino M, Ricci F, Piccini JP, et al
    Efficacy and Safety of Non-Vitamin K Antagonist Oral Anticoagulants After Cardioversion for Nonvalvular Atrial Fibrillation.
    Am J Med. 2016;129:1117-1123.
    PubMed     Text format     Abstract available


  14. PEREG D, Rozenbaum Z, Vorobeichik D, Shlomo N, et al
    Prevalence and Significance of Unrecognized Renal Dysfunction in Patients with Stroke.
    Am J Med. 2016;129:1074-81.
    PubMed     Text format     Abstract available


  15. PROIETTI M, Lip GY
    Major Outcomes in Atrial Fibrillation Patients with One Risk Factor: Impact of Time in Therapeutic Range Observations from the SPORTIF Trials.
    Am J Med. 2016;129:1110-6.
    PubMed     Text format     Abstract available


    May 2016
  16. RUFF CT, Ansell JE, Becker RC, Benjamin EJ, et al
    North American Thrombosis Forum, AF Action Initiative Consensus Document.
    Am J Med. 2016;129.
    PubMed     Text format     Abstract available


    November 2015
  17. AVINA-ZUBIETA JA, Man A, Yurkovich M, Huang K, et al
    Early Cardiovascular Disease After the Diagnosis of Systemic Sclerosis.
    Am J Med. 2015 Nov 18. pii: S0002-9343(15)01051.
    PubMed     Text format     Abstract available


  18. LARSEN KS, Pottegard A, Lindegaard HM, Hallas J, et al
    Effect of Allopurinol on Cardiovascular Outcomes in Hyperuricemic patients A Cohort Study.
    Am J Med. 2015 Nov 14. pii: S0002-9343(15)01047.
    PubMed     Text format     Abstract available


    October 2015
  19. CAVENDER MA, Scirica BM, Raz I, Steg PG, et al
    Cardiovascular Outcomes of Patients in SAVOR-TIMI 53 by Baseline Hemoglobin A1c.
    Am J Med. 2015 Oct 30. pii: S0002-9343(15)01017.
    PubMed     Text format     Abstract available


  20. CHAUHAN V
    Hypothyroidism was 300% More Frequent than Hyperthyroidism in Patients with Atrial Fibrillation Enrolled Over 10 Years.
    Am J Med. 2015;128:e51.
    PubMed     Text format    


    September 2015
  21. RENDA G, di Nicola M, De Caterina R
    Net Clinical Benefit of Non-vitamin K Antagonist Oral Anticoagulants Versus Warfarin in Phase III Atrial Fibrillation Trials.
    Am J Med. 2015;128:1007-14.
    PubMed     Text format     Abstract available


  22. ARGULIAN E, Conen D, Messerli FH
    Misconceptions and Facts About Atrial Fibrillation.
    Am J Med. 2015;128:938-42.
    PubMed     Text format     Abstract available


    August 2015
  23. MOHSENIN V
    Obstructive sleep apnea: a new preventive and therapeutic target for stroke: a new kid on the block.
    Am J Med. 2015;128:811-6.
    PubMed     Text format     Abstract available


    July 2015
  24. CAMERON SJ, Laskurain E, Holcman K, Richeson JF, et al
    Treacherous Travelers: Emboli.
    Am J Med. 2015;128:695-8.
    PubMed     Text format    


    June 2015
  25. BANGALORE S, Ogedegbe G, Gyamfi J, Guo Y, et al
    Outcomes with Angiotensin Converting Enzyme Inhibitors versus Other Antihypertensive Agents in Hypertensive Blacks.
    Am J Med. 2015 Jun 10. pii: S0002-9343(15)00445.
    PubMed     Text format     Abstract available


  26. HSU JC, Chan PS, Tang F, Maddox TM, et al
    Differences in anticoagulant therapy prescription in patients with paroxysmal versus persistent atrial fibrillation.
    Am J Med. 2015;128:654.
    PubMed     Text format     Abstract available


    April 2015
  27. KORNELIUS E, Chiou JY, Yang YS, Lu YL, et al
    The Diabetes Shared Care Program and Risks of Cardiovascular Events in Type 2 Diabetes.
    Am J Med. 2015 Apr 20. pii: S0002-9343(15)00316.
    PubMed     Text format     Abstract available


    March 2015
  28. HOWARD VJ, Tanner RM, Anderson A, Irvin MR, et al
    Apparent Treatment-Resistant Hypertension among Individuals with History of Stroke or Transient Ischemic Attack.
    Am J Med. 2015 Mar 10. pii: S0002-9343(15)00179.
    PubMed     Text format     Abstract available


    February 2015
  29. SALIBA W, Barnett-Griness O, Elias M, Rennert G, et al
    The association between red cell distribution width and stroke in patients with atrial fibrillation.
    Am J Med. 2015;128:192.
    PubMed     Text format     Abstract available


    October 2014
  30. BAVRY AA, Gong Y, Handberg EM, Cooper-DeHoff RM, et al
    Impact of Aspirin According to Type of Stable Coronary Artery Disease: Insights from a Large International Cohort.
    Am J Med. 2014 Oct 15. pii: S0002-9343(14)00907.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Stroke is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: